Laboratory and in vivo transport characterization of hollow fiber membranes and adjacent scar tissue that forms following their implantation in the central nervous system

Hollow fiber membrane (HFM) cell encapsulation devices use a semipermeable membrane to physically immunoisolate transplanted secretory cells from host tissues and high molecular weight solutes. Advantages inherent to macroencapsulation technology have led to extensive research towards their utilization for treating a wide range of disorders including a number of neurodegenerative diseases and diabetes. Although feasibility studies have already established the therapeutic potential of macroencapsulation technology, a common observation among these and later studies is diminishing therapeutic efficacy over a span of a few weeks following implantation of devices. Progress towards fulfilling the therapeutic potential of this technology initially recognized by investigators has potentially been hampered by inadequate diffusive transport characterization of membranes employed in studies. In addition, the potential effects of host tissue responses following central nervous system (CNS) implantation of these devices is completely unknown. To address these issues a membrane characterization instrument capable of efficiently characterizing the diffusive and convective transport properties of individual HFM segments, such as they are used in devices, was developed. The instrument was then employed to study the effects of ethanol exposure, a common sterilization method, on PAN-PVC membranes commonly used in CNS implantation macro encapsulation device studies. Lastly, the solute diffusivity properties of tissue that forms adjacent to the membranes of brain implanted transcranial access devices were investigated. Coinciding with this investigation was the development of a novel technique for examining the solute diffusivity properties in the extracellular spaces of CNS tissue.